Home/Totus Medicines/Simon Harnest

SH

Simon Harnest

Chief Financial Officer

Totus Medicines

Therapeutic Areas

Oncology Immunology & Inflammation

Totus Medicines Pipeline

Drug	Indication	Phase
TOS-358	PI3Kα mutant cancers	Phase 1
IRF5 Inhibitor	Autoimmune & Inflammatory diseases	Discovery

Leadership Team at Totus Medicines

Zelanna Goldberg

Chief Medical Officer

View full Totus Medicines profile